MEDADVISOR LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.335 AUD | 0.00% |
|
+1.52% | +55.81% |
| Apr. 24 | MedAdvisor Operating Revenue Rises 42% to AU$24.2 Million in March Quarter | MT |
| Apr. 23 | MedAdvisor's Gross Profit Climbs 48.5% in Fiscal Q3, Revenue Rises 42.4% | MT |
Presenter SpeechRobert Read (Executives)My name is Robert Read, I'm the CEO of MedAdvisor, and...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
MedAdvisor Limited is an Australia-based company that is engaged in digital medication adherence solutions. The Companyâs segments include Australia, the United States, the United Kingdom and Asia Operations. The Companyâs products suite includes Medication Management Application, PlusOne Pharmacy Software and Pharma Patient Experience Platform. The Medication Management Application connects to the pharmacy from the mobile phone. The Companyâs subsidiaries include MedAdvisor International Pty. Ltd., Health Enterprises 2 Pty. Ltd., MedAdvisor Welam UK Ltd., MedAdvisor Welam USA Inc. and Adheris, LLC.
Calendar
2024-08-28
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.335
AUD
Average target price
0.4233
AUD
Spread / Average Target
+26.37%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +55.81% | 123M | |
| +9.32% | 33.88B | |
| +21.99% | 8.35B | |
| +31.37% | 4.24B | |
| -29.99% | 2.67B | |
| -19.16% | 1.45B | |
| -25.64% | 1.33B | |
| -33.21% | 1.16B | |
| +13.25% | 1B | |
| -34.50% | 892M |
- Stock Market
- Equities
- MDR Stock
- News MedAdvisor Limited
- Transcript : MedAdvisor Limited - Pre Recorded M&A Call
